Evidence map›Paper›PMID 15479945›Full record

ArticleGenome research2004

An intermediate grade of finished genomic sequence suitable for comparative analyses.

Robert W Blakesley, Nancy F Hansen, James C Mullikin, Pamela J Thomas, Jennifer C McDowell, Baishali Maskeri, Alice C Young, Beatrice Benjamin, Shelise Y Brooks, Bradley I Coleman and 13 more

Abstract readComparative Study
In one paragraph

Article in Genome research, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Revised eutherian gene collections.BMC genomic data · 2022
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Comparative genomic analysis of eutherian kallikrein genes.Molecular genetics and metabolism reports · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Sequence assembly demystified.Nature reviews. Genetics · 2013
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Robert W BlakesleyNIH Intramural Sequencing Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Nancy F Hansen
James C Mullikin
Pamela J Thomas
Jennifer C McDowell
Baishali Maskeri
Alice C Young
Beatrice Benjamin
Shelise Y Brooks
Bradley I Coleman
Jyoti Gupta
Shi-Ling Ho
Eric M Karlins
Quino L Maduro
Sirintorn Stantripop
Cyrus Tsurgeon
Jennifer L Vogt
Michelle A Walker
Catherine A Masiello
Xiaobin Guan
NISC Comparative Sequencing Program
Gerard G Bouffard
Eric D Green

Funding

Inter- and Intra-Species Comparative SequencingZIBHG000196 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI THOMAS, JAMES · 2009 to 2025
$177.6M
Multi-Species Comparative Sequencing of Targeted GenomicZ01HG000196 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI GREEN, ERIC · 2001 to 2008
$19.1M
Comparative Genomics Unit ResearchZIAHG200330 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI MULLIKIN, JAMES C · 2009 to 2022
$17.9M
Comparative Genomics Unit ResearchZ01HG200330 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI MULLIKIN, JAMES C · 2005 to 2008
$1.6M
6 · The paper itself

Abstract

Although the cost of generating draft-quality genomic sequence continues to decline, refining that sequence by the process of "sequence finishing" remains expensive. Near-perfect finished sequence is an appropriate goal for the human genome and a small set of reference genomes; however, such a high-quality product cannot be cost-justified for large numbers of additional genomes, at least for the foreseeable future. Here we describe the generation and quality of an intermediate grade of finished genomic sequence (termed comparative-grade finished sequence), which is tailored for use in multispecies sequence comparisons. Our analyses indicate that this sequence is very high quality (with the residual gaps and errors mostly falling within repetitive elements) and reflects 99% of the total sequence. Importantly, comparative-grade sequence finishing requires approximately 40-fold less reagents and approximately 10-fold less personnel effort compared to the generation of near-perfect finished sequence, such as that produced for the human genome. Although applied here to finishing sequence derived from individual bacterial artificial chromosome (BAC) clones, one could envision establishing routines for refining sequences emanating from whole-genome shotgun sequencing projects to a similar quality level. Our experience to date demonstrates that comparative-grade sequence finishing represents a practical and affordable option for sequence refinement en route to comparative analyses.

Indexed as

GenomeSoftwareAnimalsBase SequenceChromosomes, Artificial, BacterialCloning, MolecularComputational BiologyContig MappingCosts and Cost AnalysisDatabases, GeneticExonsLemurMolecular Sequence DataPapioRatsRepetitive Sequences, Nucleic Acid

Identifiers

PMID15479945
PMCPMC525681

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.